- Exchange: NASDAQ CM
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Opexa Therapeutics Inc+ Add to Watchlist
OPXA:US1.5800 USD 0.0100 0.64%
As of 20:10:00 ET on 07/11/2014.
Company Profile for Opexa Therapeutics Inc (OPXA)
Opexa Therapeutics, Inc. is biotechnology company. The company develops cellular therapies for the treatment of multiple sclerosis, rheumatoid arthritis, pancreatic, and cardiac conditions. Opexa holds a worldwide license for an autologous T cell vaccine for rheumatoid arthritis.
Opexa Therapeutics Inc
Key Executives for Opexa Therapeutics Inc (OPXA)
|Neil K WarmaPresident/CEO||Karthik RadhakrishnanChief Financial Officer|
|Donna R RillChief Development Officer|